Abstract
Atherosclerosis as the major contributor to coronary artery disease and mortality: Atherosclerosis is the major cause of death in the United States, despite recent evidence suggesting an overall reduction in cardiovascular mortality (1–6). Findings of the International Atherosclerosis Project (7) and others (8) indicate that cardiovascular morbidity and mortality are related to the overall extent of atherosclerosis. The ubiquitous nature of atherosclerosis, even in young subjects, is well established (9). Likewise, the contribution of dyslipidemia as the most powerful predictor of coronary artery disease, with the exception of age, is well understood (10,11). Therefore, reduction (ideally, prevention) of atherosclerosis should have a major impact on cardiovascular morbidity and mortality. In this regard, both the treatment options to reduce atherosclerosis and the imaging modalities to document the progression or regression of atherosclerosis are important.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Goldman L, Cook EF. The decline in ischemic heart disease mortality rates: An analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med. 1984; 101:825–836.
Sytkowski PA, Kannel WB, D’Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease: The Framingham Heart Study. N Engl J Med. 1990; 322:1635–1641.
Kaplan GA, Cohen BA, Cohen RD, Guralnik J. The decline in ischemic heart disease mortality: Prospective evidence from the Alameda County Study. Am J. Epidemiol. 1988; 127:1131–1142.
Cohn BA, Kaplan GA, Cohen RD. Did early detection and treatment contribute to the decline in ischemic heart disease mortality? Prospective evidence from the Alameda County Study. Am J Epidemiol. 1988; 127:1143–1144.
Sempos C, Cooper R, Kovar MG, McMillen M. Divergence of the recent trends in coronary mortality for the four major race-sex groups in the United States. Am J Public Health. 1988; 78:1422–1427.
Weinstein MC, Coxson PG, Williams LW, Pass TM, Stason WB, Goldman L. Forecasting coronary heart disease incidence, mortality, and cost: The coronary heart disease policy model. Am J Public Health. 1987; 77:1417–1426.
Deupree RH, Fields RI, McMahan CA, Strong JP. Atherosclerotic lesions and coronary heart disease: Key relationships in necropsied cases. Lab Invest 1973; 28:252–262.
Daoud AS, Florentin RA, Goodale F. Diffuse coronary atherosclerosis versus isolated plaques in the etiology of myocardial infarction. Am J Cardiol 1964; 13:69–74.
Wissler RW. Update on the pathogenesis of atherosclerosis. Am J Med 1991; 91(Suppl 1B):3S–9S.
Stokes JI. Dyslipidemia as a risk factor for cardiovascular disease and untimely death: The Framingjiam Study. In: Stokes JI, Mancini M, ed. Atherosclerosis Reviews. New York: Raven Press Limited, 1988.
Simons L.A. Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 counties. Am J Cardiol 1986; 57:5G–10G.
Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987; 316:1371–1375.
Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, Bornco S, Gorlin R, Fuster V. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988; 12:56–62.
Little WC, Constantinescu M, Applegate RJ, Kutcher MA, Burrows MT, Kahl FR, Santamore WP. Can coronary angiography predict the site of subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988; 78:1157–1166.
Brown G, Albers J, Fisher LD, Schaefer SM, Lin JT, Kaplan C, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 1990; 323:1289–1298.
The Pravastatin Multinational Study Group for Cardiac Risk Patients. Effects of pravastatin in patients with serum total cholesterol levels from.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. Am J Cardiol 1993; 72:1031–1037.
Hong MK, Mintz GS, Popma JJ, Kent KM, Pichard AD, Satler LF, Leon MB. Limitations of angiography for analyzing coronary atherosclerosis progression or regression. Ann Intern Med 1994; 121:348–354.
Buchwald H, Varco RL, Matts JP, Long JM, Fitch LL, Campbell GS, et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia: Report of the program on the surgical control of the hyperlipidemias (POSCH). N Engl J Med 1990, 323:946–955.
Amtzenius A, Kromhout D, Barth JD, Reiber JHC, Bruschke AGV, Buios, B, et al. Diet, lipoproteins and progression of coronary atherosclerosis. N Engl J Med. 1985; 312:805–811.
Brensike J, Levy R, Kelsey SF, Passamani, ER, Richardson, JM, Loh, IK, et al. Effects of therapy with cholestyramine on progression of coronary atherosclerosis. Results of the NHLBI Type II coronary intervention study. Circulation. 1984; 69:313–324.
Schuler G, Hambrecht R, Schlierf G, Niebauer J, Hauser K, Neumann J, et al. Regular physical exercise and low-fat diet: Effects on progression of coronary artery disease. Circulation. 1992; 86:1–11.
Omish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet. 1990; 136:129–133.
Blankenhom D, Nessim SA, Johnson RL, San Marco ME, Azen AP, Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA. 1987; 257:3233–3240.
Brown BG, Lin JT, Kelsey S, Passamani ER, Levy RI, Dodge HT, et al. Progression of coronary atherosclerosis in patients with probably familial hypercholesterolemia. Atherosclerosis. 1989; 9(Suppl I):I–81–1–90.
Kane JP, Malloy MJ, Ports TA, Philips NR, Diehl JC, Havel RJ. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA. 1990, 264:3007–3012.
Watts GF, Lewis B, Brunt JNH, Lewis ES, Coltart DJ, Smith LDR, et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas Atherosclerosis Regression Study (STARS). Lancet. 1992; 339:563–569.
Blankenhom DH. Regression of atherosclerosis: What does it mean? Am J Med. 1991; 90(Suppl 2A):42S–47S.
de Feyter PJ, Serruys PW, Davies MJ, Richardson P, Lubsen J, Oliver MF. Quantitative coronary angiograpny to measure progression and regression of coronary atherosclerosis: Value, limitations, and implications for clinical trials. Circulation. 1991; 84:412–423.
Selzer RH, Hagerty C, Azen SP, Slebes M, Lee P, Shicore A, et al. Precision and reproducibility of quantitative coronary arteriography with application to controlled clinical trials. J Clin Invest. 1989; 83:520–526.
Coy KM, Maurer G, Siegel RJ. Intravascular ultrasound imaging: A current perspective. J Am Coll Cardiol 1991; 18:1811–1823.
Nissen SE, Gurley JC, Booth DC, DeMaria AN. Intravascular ultrasound of the coronary arteries: Current applications and future directions. Am J Cardiol 1992; 69:18H–29H.
Liebson RP, Klein LW. Intravascular ultrasound in coronary atherosclerosis: A new approach to clinical assessment. Am Heart J 1992; 123:1643–1660.
Bom N, ten Hoff H, Lancee CT, Gussenhoven WJ, Bosch JG. Early and recent intraluminal ultrasound devices. In J Cardiac Imaging 1989; 4:79–88.
Tobis JM, Mallery J, Mahon D, Lehman K, Zalesky P, Griffith J, et al. Intravascular imaging of human coronary arteries in vivo: Analysis of tissue characteristics with comparison to histologic specimens. Circulation 1991; 83:913–926.
Pandian N, Kreis A, Brockway B, Isner JM, Sacharaoff A, Boleza E, et al. Ultrasound angioscopy: Real time, two-dimensional, intraluminal ultrasound imaging of blood vessels. Am J Cardiol 1988; 62:493–494.
Potkin BN, Bartorelli AL, Gessert JM, Neville RF, Almagor Y, Roberts WC, et al. Coronary artery imaging with intravascular high-frequency ultrasound. Circulation 1990; 81:1575–1585.
Nissen SE, Grines CL, Gurley JC, Sublett K, Haynie D, Diaz C, et al. Application of a new phased-array ultrasound imaging catheter in the assessment of vascular dimensions: In vivo comparison to cineangiography. Circulation 1990; 81:660–666.
Tobis JM, Mallery JA, Gessert J, Griffith J, Mahon D, Bessen M, et al. Intravascular ultrasound cross sectional arterial imaging before and after balloon angioplasty in vitro. Circulation 1989; 80:873–882.
Nishimura RA, Edwards WE, Wames CA, Reeder GS, Holmes DR, Jr, Tajik AJ, et al. Intravascular ultrasound imaging: In vitro validation and pathologic correlation. 1990; 16:145–154.
Hodgson JM, Graham SP, Sarakus AD, Dame SG, Stephens DN, Dhillon PS, et al. Clinical percutaneous imaging of coronary anatomy using an over-the-wire ultrasound catheter system. In J Cardiac Imaging 1989; 4:186–193.
Mallery JA, Tobis JM, Griffith J, Gessert J, McRae M, Moussabeck O, et al. Assessment of normal and atherosclerotic arterial wall thickness with an intravascular ultrasound imaging catheter. Am Heart J 1990; 119:1392–1400.
Lonn E, Lockwood G, Gotlieb A, Foster S, Ryan L, Rakowski H, et al. Very high frequency intravascular ultrasound: In vitro identification and quantification of components of the human arterial wall. Circulation 1991; 84:II–675.
Velican D, Velican C. Study of coronary intimal thickening. Atherosclerosis 1985; 56:331–344.
Crawford T, Levene CI. Medial thinning in atheroma. J Path Bacterial 1953; 66:19–23.
Isner JM, Donaldson RF, Fortin AH, Tischler A, Clarke RH. Attenuation of the media of coronary arteries in advanced atherosclerosis. Am J Cardiol 1986; 58:937–939.
Gussenhoven E, Pijl A, Frietman P, Gerritsen P, Essed C, Roelandt J, et al. Thinning of the media in atherosclerosis: An in vitro/in vivo intravascular echographic study. Circulation 1990; 82:III–458.
Yamagishi M, Nissen SE, Booth DC, Gurley JC, Fischer C, DeMaria AN. Impaired nitroglycerin induced vasodilation in coronary atherosclerosis: Evidence from intravascular ultrasound. J Am Coll Cardiol 1992; 19:95A.
Mintz GS, Keller MB, Fay KG. Motorized IVUS transducer pullback permits accurate quantitative axial length measurements. Circulation 1992; 86:I–323.
Galli FC, Sudhir K, Kao AK, Hargrave VK, Fitzgerald PF, Yock PG. Direct measurements of plaque volume by three-dimensional ultrasound: Potentials and pitfalls. J Am Coll Cardiol 1992; 19:115A.
Matar FA, Mintz GS, Farb A, Douek P, Pichard AD, et al. The contribution of tissue removal to lumen improvement after directional coronary atherectomy. Am J Cardiol 1994; 74:647–650.
Rosenfield K, Losordo DW, Ramaswamy K, Pastore JO, Langevin RE, Razvi S, et al. Three-dimensional reconstruction of human coronary arteries and peripheral arteries recorded during two-dimensional intravascular examination. Circulation 1991; 84:1938–1956.
Coy KM, Park JC, Fishbem MC, Laas T, Diamond GA, Adler L, et al. ID vitro validation of three-dimensional intravascular ultrasound for the evaluation of arterial injury after balloon angioplasty. J Am Coll Cardiol 1992; 20:692–700.
Gussenhoven EJ, Essed CE, Lancee CT, Mastik F, Frietman P, van Egmond FC, et al. Arterial wall characteristics determined by intravascular ultrasound imaging: An in vitro study. J Am Coll Cardiol 1989; 14:947–952.
Coy KM, Park JC, Siegel RJ. Intravascular ultrasound imaging: From experimental studies to clinical use. Cardiovasc Imaging 1991; 3:7–11.
Nissen SE, Gurley JC, Grines CL, Booth DC, Fischer C, DeMaria AN. Coronary atherosclerosis is frequently present at angiographically normal sites: Evidence from intravascular ultrasound in man. Circulation 1990; 82:III–459.
Keren G, Douek P, Hansch E, Milner MR, Pichard AD, Leon MB. Intravascular ultrasound characteristics of atheroma in angiographically “normal” segments. J Am Coll Cardiol 1991; 17:217A.
Davidson CJ, Tenaglia AN, Buller CE, Kisslo K, Bauman R, Kisslo J. Coronary angiography underestimates post-interventional lesion stenosis and reference segment disease. Circulation 1991; 84:II–437.
Nissen SE, Gurley JC, Booth DC, Yamagishi M, Berk MR, Fausch M, et al. Mechanisms of false negative coronary arteriography: Insights from intravascular ultrasound imaging. J Am Coll Cardiol 1992; 19:140A.
Mintz GS, Painter JA, Pichard AD, Kent KM, Satler LF, Popma JJ, et al. Atherosclerosis in angiographically “normal” coronary artery reference segments: An intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 1995; 25:1479–1485.
Hodgson JM, Reddy KG, Suneja R, Sheehan HM, Lesnefsky EJ, Nair R. Intracoronary ultrasound plaque composition in non-lesional segments differs in unstable angina and stable angina patients: Evidence from intracoronary ultrasound. J Am Coll Cardiol 1992; 19:79A.
Douek PC, Bonner RF, Mintz GS, Matar F, Keren G, Leon MB. Intravascular ultrasound observations in de novo and restenosis coronary lesions. Cath Cardiovasc Diag 1992; 26:77.
Lassetter JE, Krall RC, Moddrelle DS, Jenkins RD. Intravascular ultrasound detects plaque progression earlier and more accurately than quantitative coronary arteriography. J Am Coll Cardiol 1991; 17:156A.
Gupta M, Connolly AJ, Zhu BQ, Sievers RE, Sudhir K, Sun YP, et al. Quantitative analysis of progression of atherosclerosis by intravascular ultrasound: Validation in a rabbit model. Circulation 1992; 86:I–518.
Lassetter JE, Krall RC, Moddrelle DS, Jenkins RD. Morphologic changes of the arterial wall during regression of experimental atherosclerosis. Circulation 1992; 86:1–518.
St Goar FG, Pinto FJ, Alderman EL, Fitzgerald PJ, Stinson EB, Billingham ME, et al. Detection of coronary atherosclerosis in young adult hearts using intravascular ultrasound. Circulation 1992; 86:756–763.
Ventura HO, Jain A, Mesa JE, Collins TJ, White CJ, Ramee SR, et al. Intravascular ultrasound: Progression of allograft coronary artery disease in cardiac transplantation recipients. J Am Coll Cardiol 1992; 19:173A.
Pinto FJ, St Goar FG, Alderman EL, Valentine HA, Schroeder JS, Stinson EB, et al. Utility of a new classification of transplantation coronary artery disease using intravascular ultrasound. J Am Coll Cardiol 1992; 19:173A.
St Goar FG, Pinto FJ, Alderman EL, Valentine HA, Schroeder JS, Gao SZ, et al. Intracoronary ultrasound in cardiac transplant recipients: la vivo evidence of “angiographically silent” intimal thickening. Circulation 1992; 85:979–987.
Fitzgerald FJ, St Goar FG, Connolly AJ, Pinto FJ, Billingham ME, Popp RL, et al. Intravascular ultrasound imaging of coronary arteries. Is three layers the norm? Circulation 1992; 86:154–158.
Nissen SE, Yamigishi M, Booth DC, Gurley JC, Berk MR, Bates M, et al. Coronary intimal thickness increases with age: Evidence from intravascular ultrasound in normal and CAD patients. J Am Coll Cardiol 1992; 19:301A.
Zeiher AM, Grove A, Bleile T, Fritz R. Intravascular ultrasound characteristics of coronary arterial wall architecture of early lesions relate to risk factors for coronary artery disease. Circulation 1991; 84:11–676.
Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea. JAMA 1953; 152:1090–1093.
McNamara JJ, Molot MA, Stremple JF, Cutting RT. Coronary artery disease in combat casualties in Vietnam. JAMA 1971; 216:1185–1187.
Hausmann D, Erbel R, Alibelli-Chemarin MJ, Boksch W, Caracciolo E, Cohn JM, et al. The safety of intracoronary ultrasound: A multicenter survey of 2207 examinations. Circulation 1995; 91:623–630.
Hong MK, Hoeg JM, Vossoughi J, Hoyt RF, Wong SC, Mintz GS, Zuckerman BD, Mehlman MD, Kent KM, Leon MB. Altered vascular biomechanical properties precede angiographically detectable disease in early atherosclerosis of LDL receptor deficiency. J Am Coll Cardiol 1995; Suppl A:290A.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hong, M.K., Leon, M.B., Mintz, G.S. (1997). Usefulness of Intravascular Ultrasound for Detecting Atherosclerosis Progression Or Regression. In: Klein, L.W. (eds) Coronary Stenosis Morphology: Analysis and Implication. Developments in Cardiovascular Medicine, vol 190. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6287-0_10
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6287-0_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7886-0
Online ISBN: 978-1-4615-6287-0
eBook Packages: Springer Book Archive